Georgetown — Washington D.C., District of Columbia

Georgetown is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Clinical Trials Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Georgetown has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC).

Sponsors: Incyte Corporation, Matrix Biomed, Inc., Catherine Bollard.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown?

Georgetown has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown conducted?

Georgetown has 6 clinical trials on record, with 1 currently active. Their work covers Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC).

Is Georgetown accredited by Crixeo Clinical Trials?

Georgetown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.